Continuing Education Module 4 – Exposure Pathway Evaluation
Public Health Assessment Training
The Public Health Assessment Training (PHAT) online modules are designed to increase knowledge and competency of environmental health practices in the evaluation of exposure to hazardous substances. The content of the modules is derived from the method used by the Agency for Toxic Substances and Disease Registry (ATSDR), which is known as the public health assessment (PHA).
At the conclusion of Module 4: Exposure Pathway Evaluation, the participant will be able to:
- Describe the importance of the exposure evaluation.
- Define what it means to be exposed.
- Name the five elements of an exposure pathway.
- List factors to consider to evaluate the elements of an exposure pathway.
- Identify SMEs who could help in effectively evaluating the fate and transport of hazardous substances at contaminated sites.
- Identify the different categories of an exposure pathway.
- Apply tips to conduct the exposure evaluation.
- Evaluate the GLC site’s exposure pathways.
- Carla Buriks MS BS, Project Manager/Education Specialist, Tetra Tech, Inc.
- Gregory M. Zarus MS MS BS, Lead Environmental Health Scientist, ATSDR
- Lynn Wilder PhD CIH, Associate Director for Science, National Center for Environmental Health
- Sandra López-Carreras MS BS, Environmental Health Scientist/Training Coordinator, ATSDR
Origination Date: January 24, 2020
Renewal Date: January 24, 2022
Expiration Date: January 24, 2024
Hardware/Software: Computer Hardware; Internet connection; Browser, Word, Adobe
Public health professionals involved or interested in the PHA process, including Environmental Health Specialists, Toxicologists, Epidemiologists, Medical Officers, Registered Nurses, Health Educators, Community Involvement Specialists, Health Communicators, and Program Managers.
Format: These modules are online, asynchronous, and self-paced.
Sandra M. López-Carreras MS, firstname.lastname@example.org, 770-488-0663
In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this enduring material for a maximum of (1.5) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides (1.4) contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer (0.1) CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
For Certified Public Health Professionals (CPH)
The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 2.0 CPH recertification credits for this program.
In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
CDC did not accept commercial support for this continuing education activity.
Instructions for Obtaining Continuing Education (CE)
In order to receive continuing education (CE) for WB2921 – Public Health Assessment Training. Module 4: Exposure Pathway Evaluation please visit TCEO and follow these 9 Simple Steps before 01/24/2022, 11:59 PM (ET). Use the “WB2921” course number to search for this course.